SIM
FOLD

Strategic Investment Management’s Amicus Therapeutics FOLD Stock Holding History

Strategic Investment Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-29,098
Closed -$215K – 128
2016
Q3 		$215K Sell
29,098
-19,443
-40% -$131K 0.15% 67
2016
Q2 		$265K Buy
+48,541
New +$339K 0.14% 45
2015
Q1 		– Sell
-14,388
Closed -$119K – 123
2014
Q4 		$119K Buy
+14,388
New +$98.8K 0.03% 88

Other funds holding FOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Strategic Investment Management's FOLD Position: Q4 2016 in Review

Strategic Investment Management sold out of Amicus Therapeutics (FOLD) in Q4 2016, closing a stake of 29,098 shares — an estimated $215K sold.

Strategic Investment Management first reported a position in FOLD in Q4 2014 and held it in 3 quarters. The position peaked at $265K in Q2 2016. 135 funds tracked by Wall St. Rank hold FOLD as of Q4 2016.

  • Strategic Investment Management reported no remaining Amicus Therapeutics position as of Q4 2016 after selling out during the quarter.
  • Strategic Investment Management sold 29,098 Amicus Therapeutics shares in Q4 2016, an estimated $215K.
  • Strategic Investment Management first reported a position in Amicus Therapeutics in Q4 2014 and held it in 3 quarters.
  • Strategic Investment Management's Amicus Therapeutics position peaked at $265K in Q2 2016.
  • 135 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2016.

Based on Strategic Investment Management's 13F filing for Q4 2016, filed 15 Feb 2017.